Drugs / Trivalent Inactivated Split Virion Influenza Vaccine
Trivalent Inactivated Split Virion Influenza Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01538940 | Nov 2011 → Sep 2013 | influenza | Centers for Disease Control and Prevention | Completed | Missed primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Trivalent Inactivated Split Virion Influenza Vaccine | “Randomized Controlled Trial to Compare the Immunogenicity of Intramuscular Versus Intradermal Trivalent Inactivated Split Virion Influenza Vaccine in HIV-infected Men Who Have...” NCT01538940 ↗ |
| Modality | Vaccine | “trivalent inactivated influenza vaccine” NCT01538940 ↗ |
| Route | Intramuscular | “standard full-dose intramuscular vaccine” NCT01538940 ↗ |